In diabetic kidney disease (DKD), conditions such as hyperglycemia, hypoxia, and lipid metabolism disorders upregulate levels of TLR4 ligands, including HMGB1, biglycan, and S100 calcium-binding protein (S100A8) (185–187). Here, BGN is linked to diabetic kidney disease.